Investor Stock List
Ranked #3,285 of 8,699 institutional investors

Saturn V Capital Management LP

Austin, TX

$587M
US stock portfolio at live prices · today −$13.8M (−2.29%)
Live prices, last trade 11:35 AM ET
Value at quarter end (Q3 2026)
$683M
Change from Q2 2026
−$14.3M (−2.06%)
Positions
20 · 3 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$95.4M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
AMLX 19.7%IRON 7.82%PCVX 7.49%ABVX 6.26%IMMX 5.75%
StockSharesValue, live% of portfoliovs Q2 2026
AMLX Amylyx Pharmaceuticals, Inc.4,471,356$116M19.7%Reduced −3%
IRON Disc Medicine, Inc.612,661$45.9M7.82%Added +17%
PCVX Vaxcyte, Inc.772,258$44.0M7.49%Reduced −9%
ABVX ABIVAX Société Anonyme529,313$36.8M6.26%Added +2%
IMMX Immix Biopharma, Inc.4,661,115$33.7M5.75%Unchanged
CELC Celcuity Inc.513,847$28.1M4.79%Added +39%
XFOR X4 Pharmaceuticals, Inc.7,366,442$21.9M3.73%Added +6%
MNPR Monopar Therapeutics Inc.312,350$21.3M3.63%Added +0%
TRVI Trevi Therapeutics, Inc.1,573,876$21.0M3.57%Added +50%
SGMT Sagimet Biosciences Inc.2,002,813$18.2M3.10%Added +35%
CADL Candel Therapeutics, Inc.3,476,206$17.8M3.03%Added +5%
VIR Vir Biotechnology, Inc.2,040,422$17.6M3.00%Added +165%
DYN Dyne Therapeutics, Inc.837,175$13.3M2.26%Reduced −21%
ANRO Alto Neuroscience Inc518,109$13.1M2.23%Added +183%
RARE Ultragenyx Pharmaceutical Inc.758,771$12.6M2.15%New
ALMS Alumis Inc.2,855,811$11.6M1.98%Reduced −2%
ERAS Erasca, Inc.514,309$7.2M1.23%New
IKT Inhibikase Therapeutics, Inc.3,869,056$5.0M0.86%Unchanged
LTGO Latigo Biotherapeutics, Inc.300,355$3.9M0.67%New
MSLE Satellos Bioscience Inc.516,800$3.0M0.52%Added +48%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
IVVD Invivyd, Inc.8,392,288$3.8M
OVID Ovid Therapeutics Inc.663,060$1.5M